Interpreting estimates of treatment effects: Implications for managed care

P and T

Volumn 33, Issue 12, 2008, Pages

  Faraone, Stephen V ^a,b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Department of Psychiatry and Behavioral Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

MANAGED CARE; OUTCOMES RESEARCH; REVIEW; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 58449086108     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50(6):683-691.
2. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ 2003; 326(7387):472.
3. Chou R, Fu R, Huffman LH, Korthuis PT. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: Discrepancies between direct and indirect meta-analyses. Lancet 2006;368(9546):1503-1515.
4. Cook RJ, Sackett DL. The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995;310(6977):452-454.
5. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
6. McGraw KO, Wong SP. A common language effect size statistic. Psychol Bull 1992;111:361-365.
7. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143(1):29-36.
8. Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of medical technology: The probability of a better outcome. Int J Technol Assess Health Care 1988;4(4):637-642.
9. Faraone SV, Biederman J, Spencer TJ, Wilens TE. The drug-placebo response curve: A new method for assessing drug effects in clinical trials. J Clin Psychopharmacol 2000;20(6):673-679.
10. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006; 59(11):990-996.
11. Faraone SV, Biederman J, Spencer T, et al. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: A drug-placebo response curve analysis. Behav Brain Functions 2005;1(1):16.
12. Faraone S, Short E, Biederman J, et al. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: A drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol 2002;5(2):121-129.
13. Faraone SV, Pliszka SR, Olvera RL, et al. Efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: A drug-placebo and drug-drug response curve analysis. J Child Adolesc Psychopharmacol 2001;11(2):171-180.
14. Short EJ, Manos MJ, Findling RL, Schubel EA. A prospective study of stimulant response in preschool children: Insights from ROC analyses. J Am Acad Child Adolesc Psychiatry 2004;43(3): 251-259.
15. Tiihonen J, Hallikainen T, Ryynanen OP et al. Lamotrigine in treatment-resistant schizophrenia: A randomized placebo-controlled crossover trial. Biol Psychiatry 2003;54(11):1241-1248.
16. Stata User's Guide: Release 9. College Station, TX: Stata Corporation, LP; 2005.
17. Gale C, Oakley-Browne M. Generalised anxiety disorder. Clin Evid 2002(7):883-895.
18. Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. Medscape General Medicine e Journal 2006;8(4):4.
19. Faraone SV. Understanding the effect size of ADHD medications: Implications for clinical care. Medscape Psychiatry Mental Health 2003;8(2).
20. Geddes J, Butler R. Depressive disorders. Clin Evid 2002(7): 867-882.
21. Soomro GM. Obsessive compulsive disorder. Clin Evid 2002(7): 896-905.
22. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side-effects of the hew antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials. Schizophr Res 1999;35(1):51-68.